Literature DB >> 10199884

Serial assessment of sympathetic reinnervation after orthotopic heart transplantation. A longitudinal study using PET and C-11 hydroxyephedrine.

F M Bengel1, P Ueberfuhr, S I Ziegler, S Nekolla, B Reichart, M Schwaiger.   

Abstract

BACKGROUND: Little is known about the progressiveness of sympathetic reinnervation late after cardiac transplantation (HTX). The aim of the present study was to describe individual growth of sympathetic terminals after HTX by a longitudinal quantitative assessment. METHODS AND
RESULTS: In 20 patients after HTX, dynamic PET with C-11 hydroxyephedrine (HED) was performed twice within 3.0+/-0.5 years. According to the time interval between HTX and first PET, subgroups of patients early (group A, <1.5 years; n=7), intermediate (group B, 1.5 to 7 years; n=7) and late (group C, >7 years; n=6) after HTX were defined. At the time of first HED PET, 10 patients were completely denervated (7 in group A, 2 in group B, and 1 in group C). Only 3 remained denervated at second PET. A significant increase of reinnervated myocardium between first and second PET was found in all 3 groups (0% to 9+/-9% of left ventricle for group A, P<0.05; 13+/-12% to 23+/-17% for group B, P<0.05; 21+/-21% to 37+/-23% for group C, P<0.05). The magnitude of increase was similar between groups. Reinnervation was first surveyed in the basal anterior region, then toward apex, septal, and lateral wall. Inferior wall remained denervated. The largest reinnervated area surveyed in an individuum was 66% of the left ventricle.
CONCLUSIONS: The present data confirm the low likelihood of sympathetic reinnervation within 18 months after HTX. Once the reinnervation process is initiated, a continuous growth is observed even late after HTX, suggesting a progressive nature of reinnervation. Reinnervation, however, remained regionally heterogeneous, and a complete restoration was not found until 15 years after HTX.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10199884     DOI: 10.1161/01.cir.99.14.1866

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  29 in total

Review 1.  Cardiac receptor physiology and its application to clinical imaging: present and future.

Authors:  H Tseng; J M Link; J R Stratton; J H Caldwell
Journal:  J Nucl Cardiol       Date:  2001 May-Jun       Impact factor: 5.952

Review 2.  Radionuclide imaging of cardiac autonomic innervation.

Authors:  Sang Yong Ji; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

Review 3.  Exercise after heart transplantation.

Authors:  Claudio Marconi; Mauro Marzorati
Journal:  Eur J Appl Physiol       Date:  2003-09-06       Impact factor: 3.078

4.  Cardiac receptor physiology and imaging: an update.

Authors:  Grace P Chen; Ramin Tabibiazar; Kelley R Branch; Jeanne M Link; James H Caldwell
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

Review 5.  The role of cardiac PET in translating basic science into the clinical arena.

Authors:  Paco E Bravo; Frank M Bengel
Journal:  J Cardiovasc Transl Res       Date:  2011-05-15       Impact factor: 4.132

Review 6.  Application of animal and human PET in cardiac research.

Authors:  Quan Wang; Zhi-Gang He; Shun-Yuan Li; Mao-Hui Feng; Hong-Bing Xiang
Journal:  Am J Cardiovasc Dis       Date:  2018-06-15

Review 7.  Cardiac sympathetic neuronal imaging using PET.

Authors:  Riikka Lautamäki; Dnyanesh Tipre; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

8.  11C-meta-hydroxyephedrine defects persist despite functional improvement in hibernating myocardium.

Authors:  James A Fallavollita; Michael D Banas; Gen Suzuki; Robert A deKemp; Munawwar Sajjad; John M Canty
Journal:  J Nucl Cardiol       Date:  2009-11-10       Impact factor: 5.952

Review 9.  Cardiac PET-CT for monitoring medical and interventional therapy in patients with CAD: PET alone versus hybrid PET-CT?

Authors:  Quynh A Truong; Henry Gewirtz
Journal:  Curr Cardiol Rep       Date:  2014-03       Impact factor: 2.931

10.  Infarct-derived chondroitin sulfate proteoglycans prevent sympathetic reinnervation after cardiac ischemia-reperfusion injury.

Authors:  Ryan T Gardner; Beth A Habecker
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.